A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer.
暂无分享,去创建一个
A. Brancale | A. Westwell | C. Mcguigan | S. Ferla | M. Bassetto | F. Pertusati | Sahar Khandil | C. Mcguigan* | Fabrizio Pertusati | Marcella Bassetto